Flaherty, Daniel Patrick
- Purdue University · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #8,600
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$1.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#8,600
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Flaherty, Daniel Patrick as a PI. Multi-PI records show the full award amount for context.
- 5R01AI153264-02R01Contact PIDevelopment of novel anti-Neisseria gonorrhoeae therapeutic agentsPurdue University · Pharmacology (NIH department code)$764.8Kaward amount
- 5R01NS119917-03R01Contact PIPharmacological validation of adenylyl cyclase 1 as a drug target for chronic painPurdue University · Pharmacology (NIH department code)$375.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Flaherty, Daniel Patrick as a PI.
FY2023 award administered by Purdue University (IN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardPurdue University
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #8133
- 2022R01 Grant Holder
- 2023$2M Cumulative Funding